Lee Ainslie's THC Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 2,133 shares of Tenet Healthcare Corporation (THC) worth $545,109, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in THC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2020, adding 129,895 shares. Largest reduction occurred in Q2 2020, reducing 129,895 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Tenet Healthcare Corporation (THC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenet Healthcare Corporation (THC) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +2,133 | New Buy | 2,133 | $255.56 |
| Q3 2025 | -6,729 | Sold Out | 0 | $0.00 |
| Q1 2025 | +3,872 | Add 135.53% | 6,729 | $134.50 |
| Q4 2024 | -4,857 | Reduce 62.96% | 2,857 | $126.23 |
| Q3 2024 | -156 | Reduce 1.98% | 7,714 | $166.20 |
| Q2 2024 | +7,870 | New Buy | 7,870 | $133.03 |
| Q1 2024 | -10,153 | Sold Out | 0 | $0.00 |
| Q4 2023 | +3,379 | Add 49.88% | 10,153 | $75.57 |
| Q3 2023 | -2,733 | Reduce 28.75% | 6,774 | $65.89 |
| Q2 2023 | +641 | Add 7.23% | 9,507 | $81.38 |
| Q1 2023 | -980 | Reduce 9.95% | 8,866 | $59.42 |
| Q4 2022 | +2,815 | Add 40.04% | 9,846 | $48.79 |
| Q3 2022 | +7,031 | New Buy | 7,031 | $51.63 |
| Q1 2022 | -1,750 | Sold Out | 0 | $0.00 |
| Q4 2021 | -13,830 | Reduce 88.77% | 1,750 | $81.71 |
| Q3 2021 | -12,184 | Reduce 43.88% | 15,580 | $66.43 |
| Q2 2021 | +24,508 | Add 752.70% | 27,764 | $66.99 |
| Q1 2021 | +1,878 | Add 136.28% | 3,256 | $51.90 |
| Q4 2020 | -787 | Reduce 36.35% | 1,378 | $39.91 |
| Q3 2020 | +2,165 | New Buy | 2,165 | $24.48 |
| Q2 2020 | -129,895 | Sold Out | 0 | $0.00 |
| Q1 2020 | +129,895 | New Buy | 129,895 | $14.40 |
| Q4 2019 | -110,571 | Sold Out | 0 | $0.00 |
| Q3 2019 | +110,571 | New Buy | 110,571 | $22.12 |
| Q2 2019 | -102,370 | Sold Out | 0 | $0.00 |
| Q1 2019 | +102,370 | New Buy | 102,370 | $28.84 |
| Q2 2018 | -72,680 | Sold Out | 0 | $0.00 |
| Q1 2018 | +72,680 | New Buy | 72,680 | $24.24 |
Lee Ainslie's Tenet Healthcare Corporation Investment FAQs
Lee Ainslie first purchased Tenet Healthcare Corporation (THC) in Q1 2018, acquiring 72,680 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Tenet Healthcare Corporation (THC) for 29 quarters since Q1 2018.
Lee Ainslie's largest addition to Tenet Healthcare Corporation (THC) was in Q1 2020, adding 129,895 shares worth $1.87 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 2,133 shares of Tenet Healthcare Corporation (THC), valued at approximately $545,109.
As of the Q3 2026 filing, Tenet Healthcare Corporation (THC) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Tenet Healthcare Corporation (THC) was 129,895 shares, as reported at the end of Q1 2020.